Novel crystalline forms of 1-(4-{ [6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl} -piperidin-1-yl)-propenone

The present invention relates to crystalline forms of 1-(4-{ [6-Amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl} -piperidin-1-yl)-propenone, a.k.a evobrutinib, useful as BTK inhibitors.

Bibliographische Detailangaben

Hauptverfasser:	Saal, Christoph, Poma, Marco, Burini, Edoardo, Theuerkorn, Vedad, Becker, Axel
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!